Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Nuvation Bio Inc.(NUVB) | 8,081,089 | 8,081,089 | 0 | 34,668 | 45,901 | 24.72% | +11,233 |
| Beta Bionics Inc. | 1,316,183 | 1,316,183 | 0 | 13,188 | 20,625 | 11.11% | +7,436 |
| Bicara Therapeutics Inc. | 2,392,150 | 1,822,150 | -570,000 | 47,580 | 54,100 | 29.14% | +6,520 |
| Kestra Med Technologies Ltd SHS | 1,022,149 | 1,022,149 | 0 | 20,371 | 26,003 | 14.00% | +5,632 |
| Alumis Inc. | 241,255 | 241,255 | 0 | 5,315 | 6,789 | 3.66% | +1,474 |
| Sana Biotechnology, Inc.(SANA) | 843,750 | 843,750 | 0 | 2,430 | 2,945 | 1.59% | +515 |
| ImageneBio, Inc. | 455,361 | 455,361 | 0 | 2,277 | 2,687 | 1.45% | +410 |
| Odyssey Therapeutics Inc. | 0 | 2,893 | +2,893 | 0 | 54 | 0.03% | +54 |
| Replimune Group(REPL) | 248,672 | 0 | -248,672 | 1,910 | 0 | — | -1,910 |
| BridgeBio Oncology Therapeutics Inc. | 3,289,661 | 3,289,661 | 0 | 29,442 | 25,067 | 13.50% | -4,375 |
| enGene Holdings Inc. COM | 876,357 | 876,357 | 0 | 5,968 | 1,516 | 0.82% | -4,452 |